期刊
STEM CELL REVIEWS AND REPORTS
卷 14, 期 4, 页码 484-499出版社
SPRINGER
DOI: 10.1007/s12015-018-9817-x
关键词
MSC; Secretome; Cell-free therapy; Condition medium; Therapeutic agents
资金
- Guilan University of Medical Sciences [IR.GUMS.REC.1396.343]
- Grants-in-Aid for Scientific Research [16K00538] Funding Source: KAKEN
Over 10 years, mesenchymal stem cells (MSCs) have been considered as valuable and suitable cells for cell-based therapy applications, particularly in clinical trials. In any case, they are as yet not utilized routinely in clinics. At first, it was believed that MSCs play their roles, especially in regenerative medicine due to their differentiation and cell replacement properties. Interestingly, it is well-known that MSCs mainly exert their therapeutic effects through their vast bioactive factors. These findings turned scientists' consideration toward cell-free therapy concepts. From this point of view, MSCs can be considered as an arsenal of natural bioreactors in variety of therapeutic agents. MSCs inherently express various important therapeutic agents such as growth factors and cytokines that can be manufactured, handled and stored as a prepared-to-go biologic product. In this review, we provide a vision, highlight as well as discuss in order to introduce competitive natural robust bioreactor MSCs on the horizon.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据